Gianluca Bargagli

CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab

Roberto Petrioli, Antonella Licchetta, Giandomenico Roviello et al. · Cancer Investigation · 2012 · 31 citations

Gastrointestinal Oncology, Medicine, Oxaliplatin-based Chemotherapy +12

Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab

Filippo Francini, Alessandra Pascucci, Edoardo Francini et al. · The Journal of the American Dental Association · 2011 · 31 citations

Bone Disease, Zoledronic Acid, Bone Health +5

Effects of intravenous zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from non-small cell lung cancer

Filippo Francini, Alessandra Pascucci, Gianluca Bargagli et al. · International Journal of Clinical Oncology · 2011 · 19 citations · Full text

Bone Disease, Bone Health, Oral Ibandronate +10

HLA antigens and primary osteoarthritis of the hand.

Daniela Merlotti, Clorinda Santacroce, Luigi Gennari et al. · PubMed · 2003 · 17 citations

Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin

Roberto Petrioli, Gianluca Bargagli, Stefano Lazzi et al. · Anti-Cancer Drugs · 2010 · 17 citations · Full text